Metabolic side effects of atypical antipsychotics in children: a literature review
- 1 September 2005
- journal article
- research article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 19 (5), 533-550
- https://doi.org/10.1177/0269881105056543
Abstract
The objective of this review is to summarize the data about metabolic side effects of atypical antipsychotics in children. Original research articles about side effects of atypical antipsychotics used in children were reviewed. The data was obtained mainly through Medline searches, identifying articles focusing on the use of atypical antipsychotics in children. Forty studies that addressed the issue of metabolic side effects were selected. The use of atypical antipsychotics in children has been consistently associated with weight gain and moderate prolactin elevation, while only a few case reports address the issue of glucose dysregulation and dyslipidaemia. The risk of weight gain and hyperprolactinaemia might be higher in younger children. Other risk factors have also been associated with antipsychotic-induced metabolic disturbances. These changes seem to be reversible, at least in some cases. Metabolic side effects of atypical antipsychotics could lead to serious complications in children who are prescribed these medications. Serious considerations should be given before initiating treatment and consistent clinical monitoring is essential. More research is needed, especially regarding glucose dysregulation and dyslipidaemia.This publication has 99 references indexed in Scilit:
- Weight Gain Associated with Atypical Antipsychotic Use in Children and AdolescentsPediatric Drugs, 2004
- Quetiapine Treatment of Children and Adolescents with Tourette's DisorderJournal of Child and Adolescent Psychopharmacology, 2003
- Hyperglycemia from Olanzapine Treatment in AdolescentsJournal of Child and Adolescent Psychopharmacology, 2003
- Trends in Antipsychotic Use in a Texas Medicaid Population of Children and Adolescents: 1996 to 2000Journal of Child and Adolescent Psychopharmacology, 2002
- Correlation of Antipsychotic and Prolactin Concentrations in Children and Adolescents Acutely Treated with Haloperidol, Clozapine, or OlanzapineJournal of Child and Adolescent Psychopharmacology, 2002
- A Study of Quetiapine: Efficacy and Tolerability in Psychotic AdolescentsJournal of Child and Adolescent Psychopharmacology, 2001
- Neural Plasticity: From the Laboratory to the ClinicianJournal of Psychiatric Practice, 2000
- Paediatric uses of atypical antipsychoticsExpert Opinion on Pharmacotherapy, 2000
- Elevated Prolactin in Pediatric Patients on Typical and Atypical AntipsychoticsJournal of Child and Adolescent Psychopharmacology, 1999
- Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptorsNature, 1995